Apheresis Equipment Market: By Product Type (Equipment for Donor Apheresis Equipment & Therapeutics Apheresis Equipment), By Disease(Neurological, Blood, Cardiovascular Disorders, Other Disorders), By Procedure & Geography - Forecast (2014-2021)

  • ID: 3919917
  • Report
  • 143 pages
  • IndustryARC
1 of 3
Apheresis is a process which involves removal of whole blood from a patient or donor. Apheresis equipment is a machine which is used to remove the blood and is designed as a centrifuge, the components of whole blood are separated. One of the separated portion of the blood is withdrawn while re-transfusing the other portion. Globally demand for such machines is expected to grow significantly and is expected to be driven by factors such as increasing instances of blood disorders and growing demand for blood and blood components.

This report identifies the apheresis equipment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to apheresis equipment market.

Globally North America dominated the market for apheresis equipment in 2015 and is expected to continue its dominance during the period of study due to higher usage and adoption of advanced medical technologies. North America was followed by Europe and Asia-Pacific as the second and third largest markets respectively for apheresis equipment in 2015. Demand for apheresis equipment in Asia-Pacific is expected to witness fastest growth in the near future due to constantly growing demand of blood components for transfusion from increasing surgical procedures and higher accidents & trauma cases, rapid development in the healthcare infrastructure in the region.

This report on global apheresis equipment is segmented on the basis of various types of apheresis equipment by product type, by disease, by procedure type and market size in various geographical regions.
On the basis of product types report classified as follows covering all major types of apheresis equipment as follows: Equipment for Donor Apheresis Equipment and Equipment for Therapeutics Apheresis Equipment

On the basis of disease treated, this report is segmented as follows covering all the major type of treated disease as follows: Neurological Disorders, Blood Disorders, Cardiovascular Disorders, Renal Disorders, Autoimmune Disorders, Metabolic Disorders and Other Disorders

On the basis of procedure followed, global apheresis equipment market is segmented as follows covering all major procedures used: Therapeutic Plasma Exchange (TPE), Therapeutic CytApheresis Equipment, Photopheresis, Extracorporeal Immunoadsorption (ECI), Low-Density Lipoprotein (LDL) Apheresis Equipment

This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for apheresis equipment in each of the region.

This report identifies all the major companies operating in the global apheresis equipment market. Some of the major companies’ profiles in detail are as follows:
Asahi Kasei Kuraray Medical Co Ltd.
B. Braun Melsungen AG
Kawasumi Laboratories Inc.
Terumo BCT Inc.
Haemonetics Corporation
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Apheresis Equipment - Market Overview
2. Executive Summary
3. Apheresis Equipment Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Apheresis Equipment - Market Forces
4.1. Drivers
4.1.1. Growing prevalence for blood disorders and increasing demand for blood & blood components
4.1.2. Increasing demand for therapeutic Apheresis Equipment in cancer treatment
4.2. Restraints
4.2.1. Lack of awareness among patients
4.3. Opportunities
4.4. Challenges
4.4.1. High cost of Apheresis Equipment
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Apheresis Equipment Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Global Apheresis Equipment Market, By Product Type (2014-2021)
6.1. Equipment for Donor Apheresis Equipment
6.2. Equipment for Therapeutics Apheresis Equipment
7. Global Apheresis Equipment Market, By Disease (2014-2021)
7.1. Neurological Disorders
7.2. Blood Disorders
7.3. Cardiovascular Disorders
7.4. Renal Disorders
7.5. Autoimmune Disorders
7.6. Metabolic Disorders
7.7. Other Disorders
8. Global Apheresis Equipment Market, By Procedure (2014-2021)
8.1. Therapeutic Plasma Exchange (TPE)
8.2. Therapeutic CytApheresis Equipment
8.3. Photopheresis
8.4. Extracorporeal Immunoadsorption (ECI)
8.5. Low-Density Lipoprotein (LDL) Apheresis Equipment
9. Global Apheresis Equipment Market, By Geography (2014-2021)
9.1. Europe
9.1.1. Germany
9.1.2. France
9.1.3. Italy
9.1.4. Spain
9.1.5. Russia
9.1.6. U.K.
9.1.7. Rest of Europe
9.2. Asia Pacific
9.2.1. China
9.2.2. India
9.2.3. Japan
9.2.4. South Korea
9.2.5. Rest of Asia-Pacific
9.3. North America
9.3.1. U.S.
9.3.2. Canada
9.3.3. Mexico
9.4. Rest of the World (RoW)
9.4.1. Brazil
9.4.2. Rest of RoW
10. Apheresis Equipment - Market Entropy
10.1. Expansion
10.2. Technological Developments
10.3. Merger & Acquisitions, and Joint Ventures
10.4. Supply - Contract
11. Company Profiles (Top 10 Companies)
11.1. Asahi Kasei Kuraray Medical Co Ltd.
11.1.1. Introduction
11.1.2. Financials
11.1.3. Key Insights
11.1.4. Key Strategy
11.1.5. Product Portfolio
11.1.6. SWOT Analysis
11.2. B. Braun Melsungen AG
11.2.1. Introduction
11.2.2. Financials
11.2.3. Key Insights
11.2.4. Key Strategy
11.2.5. Product Portfolio
11.2.6. SWOT Analysis
11.3. Kawasumi Laboratories Inc.
11.3.1. Introduction
11.3.2. Financials
11.3.3. Key Insights
11.3.4. Key Strategy
11.3.5. Product Portfolio
11.3.6. SWOT Analysis
11.4. Terumo BCT Inc.
11.4.1. Introduction
11.4.2. Financials
11.4.3. Key Insights
11.4.4. Key Strategy
11.4.5. Product Portfolio
11.4.6. SWOT Analysis
11.5. Haemonetics Corporation
11.5.1. Introduction
11.5.2. Financials
11.5.3. Key Insights
11.5.4. Key Strategy
11.5.5. Product Portfolio
11.5.6. SWOT Analysis
11.6. Nikkiso Co., Ltd.
11.6.1. Introduction
11.6.2. Financials
11.6.3. Key Insights
11.6.4. Key Strategy
11.6.5. Product Portfolio
11.6.6. SWOT Analysis
11.7. Cerus Corporation
11.7.1. Introduction
11.7.2. Financials
11.7.3. Key Insights
11.7.4. Key Strategy
11.7.5. Product Portfolio
11.7.6. SWOT Analysis
11.8. Fresenius Se & Co. KGAA
11.8.1. Introduction
11.8.2. Financials
11.8.3. Key Insights
11.8.4. Key Strategy
11.8.5. Product Portfolio
11.8.6. SWOT Analysis
11.9. Medica S.P.A
11.9.1. Introduction
11.9.2. Financials
11.9.3. Key Insights
11.9.4. Key Strategy
11.9.5. Product Portfolio
11.9.6. SWOT Analysis
11.10. Kaneka Corporation
11.10.1. Introduction
11.10.2. Financials
11.10.3. Key Insights
11.10.4. Key Strategy
11.10.5. Product Portfolio
11.10.6. SWOT Analysis

"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown